Venture Capital

Dr. Bill Winston's 2026 conference gathers global leaders to merge spiritual principles with business strategy in a complex economic landscape.

LymeFiber partners with gaiia, deploying an AI-driven platform to overcome operational hurdles and deliver high-speed internet to a once-underserved town.

A new growth medium aims to standardize stem cell production, addressing key regulatory and scalability challenges in the booming regenerative medicine market.

With strong revenue growth and critical FDA decisions on the horizon, MannKind's leadership prepares to outline its vision for investors in Miami.

In a booming aesthetics market, one company is enlisting elite surgeons to architect the future of recovery, aiming to close a critical gap in patient care.

As AI's energy demand soars, Aalo Atomics partners with Baker Hughes to build advanced nuclear reactors for data centers, a pivotal step toward a new era.

As Sera Prognostics preps its year-end report, investors watch to see if its groundbreaking preterm birth test can deliver financial health.

Fresh off a blockbuster IPO, SpyGlass Pharma heads to a key investor summit. Can its revolutionary long-acting drug platform transform chronic eye care?

With $3M in funding and a key industry partnership, PartsPulse is launching its agentic AI platform to unify the chaotic aftermarket parts industry.

As the RV market soars, roadsurfer hosts nationwide events to lure new travelers. Is it a friendly invite or a strategic play to dominate the road?

Despite a full-year GAAP loss, AFC declares a dividend and shifts its strategy post-BDC conversion. Can it resolve legacy loans and find new growth?

After a rough earnings report sent its stock tumbling, WEBTOON Entertainment heads to key investor conferences to pitch its long-term IP and creator vision.

A new UK facility, backed by government funds, will be the only one of its kind, aiming to accelerate drug development and boost domestic life sciences.

The VCT posts flat returns but rewards investors with a special dividend, announcing a new chair as it navigates a shifting regulatory landscape.

Infinitas Capital plans a 2026 IPO to offer public investors no-fee access to its exclusive portfolio of private growth companies, disrupting traditional PE.

With a NASDAQ bell ringing set, SuRo Capital's upcoming earnings will test if its big bets on private AI firms have paid off for public investors.

An industry-first collaboration uses microbes to recycle copper from old PCs into new ones, tackling the e-waste crisis and securing supply chains.

A landmark Japan-international partnership aims to break down barriers and accelerate revolutionary stem cell treatments for patients worldwide.

After a brush with delisting, Singapore's Orangekloud Technology has regained Nasdaq compliance, allowing it to focus on its AI-powered no-code platform.

The aftermarket giant launches two revolutionary caps, blending high-tech design and extreme durability to meet the demands of modern truck owners.